Plaque Psoriasis (PSO) Clinical Study Details
Living with psoriasis and obesity? Join our clinical trial evaluating an investigational treatment designed to manage both skin symptoms and weight-related health challenges. Expert care, no-cost participation, and personalized support included.
Apply To This Study Here
Please enter your name, a valid phone number, and a valid email address where you can be contacted.
Adults 18 years or older with moderate-to-severe plaque psoriasis and either obesity (BMI ≥30) or being overweight (BMI 27–29.9) with a related health condition like high blood pressure or diabetes may be eligible.
You must have been taking ixekizumab (TALTZ) for about 3 months before adding the study medication, tirzepatide, which you would start within 30 days of enrollment.
You may qualify if you have conditions like type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or heart disease along with being overweight.
Yes. You or a caregiver must be able to self-inject the medication as instructed and be comfortable following the dosing schedule. (Injection training provided)
Yes. All participants must follow birth control guidelines based on local laws and the approved use of the medications. Your study team will explain what applies to you.
You’ll need to attend all study visits, complete health questionnaires, and follow all study instructions throughout your participation.
Benefits of participating in this study
There are multiple ways you can benefit from joining us in this study. Here are some of them.
Study-related visits, evaluations, and close health monitoring are provided at no cost to participants.
Study visits include complimentary meals and transportation assistance for your appointment day.
Your participation helps researchers better understand medical conditions in a way that may benefit others, including friends, family, and future generations.